The Food and Drug Administration (FDA) says eye doctors in Indiana may have received contaminated syringes from a compounding pharmacy in Georgia.

Clinical Specialties is recalling the syringes after it received five reports of eye infections from doctors who injected the Roche drug Avastin on patients with macular degeneration. The cancer drug is approved for the off-label treatment of the eye disease.

An FDA recall notice says the company has recalled 40 lots and notified doctors in Georgia, Louisiana, and South Carolina who received the drug since December 18.

Last year, 50 people died, including 11 in Indiana, and hundreds of others were injured after contracting fungal meningitis from tainted syringes sold by the New England Compounding Center.